Smoking Cessation and Nicotine De-addiction Market cover

Smoking Cessation and Nicotine De-addiction Market by Products (Nicotine Replacement Therapy [Nicotine Spray, Nicotine Inhalers, Nicotine Gum, Nicotine Transdermal Patches, Nicotine Sublingual Tablets, and Nicotine Lozenges], Drug Therapy [Varenicline, Zyban, and Nicorette Buccal], and E-cigarettes/E-liquid) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

  • Report ID: MC-2441
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 193
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global smoking cessation and nicotine de-addiction market size is anticipated to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the high prevalence of diseases such as cardiac diseases, respiratory disorders, and lung cancer caused due to rising smoking habits among a large number of adults globally.

Smoking Cessation and Nicotine De-addiction Market summary

Nicotine de-addiction or smoking cessation involves adoption of various means or methods to stop tobacco consumption and reduce its addiction. Tobacco consists of nicotine, which is responsible for developing into addiction due to the neurotransmitters such as dopamine, glutamate, and gamma-aminobutyric acid (GABA). The products related to smoking cessation are used to stop cigarette and tobacco addicts. The market for nicotine de-addiction and smoking cessation products includes electronic cigarettes, nicotine replacement therapy (NRT), along with therapeutic drugs such as nicotine receptor agonists and anti-depressants. Several government have released policies to regulate the nicotine quantity and cigarette products to reduce the addiction as it has toxic effects on respiratory systems and heart. The government regulations on smoking cessation are increased through taxation on tobacco products, advertisements for smoking prevention and awareness, ban of smoking in public places, and provision for smoking discontinuation therapies.

The diseases or health issues related to the smoking is highly prevalent in the world as large population are addicted to smoking or tobacco consumption. As per the Center for Diseases Control and Prevention (CDC), globally tobacco causes greater than 7 million deaths every year and if this trend continues, approximately 8 million people is estimated to die due to tobacco by 2030. The same report suggests about the death of 480000 people are occurred due to tobacco in the USA alone every year, which is around one in five deaths yearly. Smoking causes several diseases such as heart disease, cancer, diabetes, lung diseases, stroke, and chronic obstructive pulmonary disease (COPD).

Market Trends, Drivers, Restraints, and Opportunities

  • Rising awareness about the smoking related diseases as well as high government initiatives for smoking prevention are driving the market expansion at a quick pace.
  • High population of smoking people and increased chronic diseases due to smoking are encouraging people to quit smoking. These are key factors for boosting the market.
  • Development of novel products for smoking and nicotine cessation is increasing the market revenue.
  • Person’s unwillingness to accept the treatment and lack of awareness regarding the treatments are major challenges that can restrain the overall market growth.
  • Increasing number of health-conscious population and governments’ policies towards tobacco cessation are huge opportunities for the market development in the near future.

Scope of the Report

The report on the global smoking cessation and nicotine de-addiction market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Smoking Cessation and Nicotine De-addiction Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Nicotine Replacement Therapy [Nicotine Spray, Nicotine Inhalers, Nicotine Gum, Nicotine Transdermal Patches, Nicotine Sublingual Tablets, and Nicotine Lozenges], Drug Therapy [Varenicline, Zyban, and Nicorette Buccal], and E-cigarettes/E-liquid)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Pfizer, Inc.; Cipla Ltd.; Novartis International AG; GlaxoSmithKline plc; Takeda Pharmaceutical Company Ltd.; McNeil AB; Revolymer plc; Imperial Tobacco Ltd.; and VMR Products, LLC.

Market Segment Insights

Nicotine replacement therapy segment is expected to grow at a rapid pace

Based on products, the global smoking cessation and nicotine de-addiction market is divided into nicotine replacement therapy, e-cigarettes, and drug therapy. The nicotine replacement therapy segment is further classified as nicotine spray, nicotine gum, nicotine inhalers, nicotine sublingual tablets, nicotine transdermal patches, and nicotine lozenges. The drug therapy segment is sub-segmented into varenicline, nicorette buccal, and zyban. The nicotine replacement therapy segment is expected to grow at a rapid pace during the forecast period owing to the factors such as easy availability, ease of use, and highly effective.

Smoking Cessation and Nicotine De-addiction Market product

The drug therapy segment, however, is expected to grow at a significant pace in the coming years attributed to the use of excessive consumption of tobacco and wide cases of withdrawal symptoms that occur when the addicted person immediately stops the use of tobacco. The varenicline drug is recommended highly as it shows good effect in smoking cessation person. It is a non-nicotine based drug and marketed as champixin in the world and as chantix in the US. Zyban is also used on large scale with combination of nicotine replacement therapy. Meanwhile, the e-cigarettes segment is growing at a fast pace as it is gaining popularity around the globe. The rechargeable feature in the product is encouraging the people to use and, hence, getting good market response.
North America is anticipated to constitute a key market share
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the projected period owing to the large number of targeted population and highly active awareness programs introduced by governments in the region. Additionally, good research activities in the field and significant awareness in the region are key factors propelling the market of the region.

Smoking Cessation and Nicotine De-addiction Market region

The Asia Pacific market, however, is expected to expand at a substantial growth rate due to the presence of high number of unmet population, high economic growth, and the presence of huge target population. Moreover, increased government interest in the smoking cessation and beneficial policies are contributing to the market development during the forecast period. The World Health Organization launched ‘national smoke-free law’ in year 2015, in Asia Pacific to encourage people to quit smoking.

Segments

Segments Covered in the Report

The global smoking cessation and nicotine de-addiction market has been segmented on the basis of

Products

  • Nicotine Replacement Therapy 
    • Nicotine Spray
    • Nicotine Inhalers
    • Nicotine Gum
    • Nicotine Transdermal Patches
    • Nicotine Sublingual Tablets
    • Nicotine Lozenges
  • Drug Therapy
    • Varenicline
    • Zyban
    • Nicorette Buccal
  • E-cigarettes/E-liquid

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Pfizer, Inc.
  • Cipla Ltd.
  • Novartis International AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Ltd.
  • McNeil AB
  • Revolymer plc
  • Imperial Tobacco Ltd.
  • VMR Products, LLC.

Competitive Landscape

The key players of the global smoking cessation and nicotine de-addiction market are Pfizer, Inc.; GlaxoSmithKline plc; Novartis International AG; Takeda Pharmaceutical Company Ltd.; Cipla Ltd.; McNeil AB; Revolymer plc; Imperial Tobacco Ltd.; and VMR Products, LLC.
Lorillard, Inc.; VMR products, LLC; NJOY; and Vapor Corp. are some of the major e-cigarettes producing companies. New product named as QuickMist, which was launched by Mcneil in 2015. The product was designed as a fast acting spray of nicotine that could act as an alternative for smoking.

Smoking Cessation and Nicotine De-addiction Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Smoking Cessation and Nicotine De-addiction Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Smoking Cessation and Nicotine De-addiction Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Smoking Cessation and Nicotine De-addiction Market - Supply Chain
  4.5. Global Smoking Cessation and Nicotine De-addiction Market Forecast
     4.5.1. Smoking Cessation and Nicotine De-addiction Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Smoking Cessation and Nicotine De-addiction Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Smoking Cessation and Nicotine De-addiction Market Absolute $ Opportunity
5. Global Smoking Cessation and Nicotine De-addiction Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Smoking Cessation and Nicotine De-addiction Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Smoking Cessation and Nicotine De-addiction Demand Share Forecast, 2019-2026
6. North America Smoking Cessation and Nicotine De-addiction Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Smoking Cessation and Nicotine De-addiction Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Smoking Cessation and Nicotine De-addiction Demand Share Forecast, 2019-2026
7. Latin America Smoking Cessation and Nicotine De-addiction Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Smoking Cessation and Nicotine De-addiction Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Smoking Cessation and Nicotine De-addiction Demand Share Forecast, 2019-2026
8. Europe Smoking Cessation and Nicotine De-addiction Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Smoking Cessation and Nicotine De-addiction Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Smoking Cessation and Nicotine De-addiction Demand Share Forecast, 2019-2026
9. Asia Pacific Smoking Cessation and Nicotine De-addiction Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Smoking Cessation and Nicotine De-addiction Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Smoking Cessation and Nicotine De-addiction Demand Share Forecast, 2019-2026
10. Middle East & Africa Smoking Cessation and Nicotine De-addiction Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Smoking Cessation and Nicotine De-addiction Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Smoking Cessation and Nicotine De-addiction Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Smoking Cessation and Nicotine De-addiction Market: Market Share Analysis
  11.2. Smoking Cessation and Nicotine De-addiction Distributors and Customers
  11.3. Smoking Cessation and Nicotine De-addiction Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Pfizer, Inc.
     11.4.2. Cipla Ltd.
     11.4.3. Novartis International AG
     11.4.4. GlaxoSmithKline plc
     11.4.5. Takeda Pharmaceutical Company Ltd.
     11.4.6. McNeil AB
     11.4.7. Revolymer plc
     11.4.8. Imper

Segments Covered in the Report

The global smoking cessation and nicotine de-addiction market has been segmented on the basis of

Products

  • Nicotine Replacement Therapy 
    • Nicotine Spray
    • Nicotine Inhalers
    • Nicotine Gum
    • Nicotine Transdermal Patches
    • Nicotine Sublingual Tablets
    • Nicotine Lozenges
  • Drug Therapy
    • Varenicline
    • Zyban
    • Nicorette Buccal
  • E-cigarettes/E-liquid

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Pfizer, Inc.
  • Cipla Ltd.
  • Novartis International AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Ltd.
  • McNeil AB
  • Revolymer plc
  • Imperial Tobacco Ltd.
  • VMR Products, LLC.

The key players of the global smoking cessation and nicotine de-addiction market are Pfizer, Inc.; GlaxoSmithKline plc; Novartis International AG; Takeda Pharmaceutical Company Ltd.; Cipla Ltd.; McNeil AB; Revolymer plc; Imperial Tobacco Ltd.; and VMR Products, LLC.
Lorillard, Inc.; VMR products, LLC; NJOY; and Vapor Corp. are some of the major e-cigarettes producing companies. New product named as QuickMist, which was launched by Mcneil in 2015. The product was designed as a fast acting spray of nicotine that could act as an alternative for smoking.

Smoking Cessation and Nicotine De-addiction Market keyplayers

Buy Report